Denise Woltemath
  • Education
  • Denise received a PharmD from the University of Nebraska School of Pharmacy and completed her clinical residency at the University of California, San Francisco

Denise Woltemath

Vice President/Custom Research

Denise Woltemath is vice president of custom research at Health Strategies Group, where she leads services that maximize the interactions of pharmaceutical and biotechnology companies with physicians and other key providers. Denise led the development of the Oncology Performance Edge service, which advises leading companies on strategies for commercial success. She recently published a groundbreaking assessment on oncology office staff, “The Total Office Call in the Oncology Market.” In the last year, she assessed over 3,500 relationships between oncology representatives and their customers to identify what matters most in developing valuable relationships. She has been a featured speaker at the Society of Pharmaceutical and Biotech Trainers Annual Conference and at the Oncology USA Summit.

Prior to joining Health Strategies Group in 2008, Denise spent more than 10 years at Bristol-Myers Squibb, most recently as the Regional Vice President of Sales. In that position she hired, developed, and motivated over 500 representatives and district managers. Other key accomplishments included developing a training initiative that doubled the length of an average sales call, directing a programmatic approach that extended the impact of promotional education programs, and creating a company-wide framework for opinion leader development. She brings more than 20 years of healthcare experience to the firm, having held leadership roles in pharmaceutical sales, managed care, medical device, and hospital settings.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.